drugset / Trial / NCT06361238
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Phase 3
Recruiting
260 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.
Timeline
- Start
- 2024-11-19
- Primary completion
- 2027-03-31
- Completion
- 2028-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 0.6 mg | Subcutaneous |